Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
13.50
-0.39 (-2.84%)
Apr 25, 2025, 9:59 AM EDT - Market open
Benitec Biopharma Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Cash & Equivalents | 78.28 | 50.87 | 2.48 | 4.06 | 19.77 | 9.8 | Upgrade
|
| Short-Term Investments | - | - | - | - | - | 0 | Upgrade
|
| Cash & Short-Term Investments | 78.28 | 50.87 | 2.48 | 4.06 | 19.77 | 9.8 | Upgrade
|
| Cash Growth | 284.23% | 1953.53% | -39.02% | -79.45% | 101.68% | -37.64% | Upgrade
|
| Accounts Receivable | - | 0.23 | 0.06 | 0 | 0.03 | 0.06 | Upgrade
|
| Other Receivables | 0 | - | - | - | - | - | Upgrade
|
| Receivables | 0 | 0.23 | 0.06 | 0 | 0.03 | 0.06 | Upgrade
|
| Prepaid Expenses | 0.37 | 0.52 | 1.18 | 0.74 | 0.8 | 0.86 | Upgrade
|
| Restricted Cash | 0.06 | 0.06 | 0.01 | 0.01 | 0.02 | - | Upgrade
|
| Other Current Assets | - | - | - | - | - | 0.09 | Upgrade
|
| Total Current Assets | 78.71 | 51.67 | 3.73 | 4.82 | 20.61 | 10.81 | Upgrade
|
| Property, Plant & Equipment | 0.29 | 0.45 | 0.61 | 0.99 | 0.58 | 0.77 | Upgrade
|
| Other Long-Term Assets | 0.07 | 0.09 | 0.12 | 0.16 | 0.19 | 0.01 | Upgrade
|
| Total Assets | 79.07 | 52.21 | 4.46 | 5.97 | 21.38 | 11.59 | Upgrade
|
| Accounts Payable | 0.59 | 1.35 | 1.14 | 0.42 | 0.27 | 0.28 | Upgrade
|
| Accrued Expenses | 0.67 | 0.65 | 0.74 | 0.7 | 0.49 | 0.46 | Upgrade
|
| Current Portion of Leases | 0.14 | 0.28 | 0.28 | 0.25 | 0.21 | 0.19 | Upgrade
|
| Other Current Liabilities | 1.69 | 2.64 | 1.82 | 1.16 | 0.39 | 0.2 | Upgrade
|
| Total Current Liabilities | 3.09 | 4.92 | 3.98 | 2.53 | 1.37 | 1.14 | Upgrade
|
| Long-Term Leases | - | - | 0.28 | 0.56 | - | 0.21 | Upgrade
|
| Total Liabilities | 3.13 | 4.96 | 4.26 | 3.09 | 1.37 | 1.35 | Upgrade
|
| Common Stock | 0 | 0 | - | - | 0 | - | Upgrade
|
| Additional Paid-In Capital | 279.3 | 238.4 | 168.92 | 152.45 | 151.58 | 128.83 | Upgrade
|
| Retained Earnings | -202.68 | -190.26 | -167.89 | -148.33 | -130.12 | -116.64 | Upgrade
|
| Comprehensive Income & Other | -0.69 | -0.89 | -0.83 | -1.25 | -1.46 | -1.95 | Upgrade
|
| Shareholders' Equity | 75.94 | 47.25 | 0.2 | 2.88 | 20.01 | 10.24 | Upgrade
|
| Total Liabilities & Equity | 79.07 | 52.21 | 4.46 | 5.97 | 21.38 | 11.59 | Upgrade
|
| Total Debt | 0.14 | 0.28 | 0.56 | 0.81 | 0.21 | 0.41 | Upgrade
|
| Net Cash (Debt) | 78.15 | 50.58 | 1.92 | 3.25 | 19.56 | 9.4 | Upgrade
|
| Net Cash Growth | 291.69% | 2537.23% | -41.00% | -83.38% | 108.11% | -40.22% | Upgrade
|
| Net Cash Per Share | 7.07 | 12.46 | 1.38 | 6.76 | 77.40 | 156.43 | Upgrade
|
| Filing Date Shares Outstanding | 23.45 | 10.56 | 2.55 | 0.48 | 0.48 | 0.07 | Upgrade
|
| Total Common Shares Outstanding | 23.45 | 10.09 | 1.65 | 0.48 | 0.48 | 0.07 | Upgrade
|
| Working Capital | 75.62 | 46.75 | -0.25 | 2.29 | 19.24 | 9.67 | Upgrade
|
| Book Value Per Share | 3.24 | 4.68 | 0.12 | 6.00 | 41.63 | 157.03 | Upgrade
|
| Tangible Book Value | 75.94 | 47.25 | 0.2 | 2.88 | 20.01 | 10.24 | Upgrade
|
| Tangible Book Value Per Share | 3.24 | 4.68 | 0.12 | 6.00 | 41.63 | 157.03 | Upgrade
|
| Machinery | 1.57 | 1.55 | 1.38 | 1.37 | 1.36 | 1.14 | Upgrade
|
| Leasehold Improvements | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.